Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma ; day:13 ; month:02 ; year:2023 ; extent:26
EMBO molecular medicine / European Molecular Biology Organization ; (13.02.2023) (gesamt 26)

Creator: Planas-Paz, Lara
Pliego‐Mendieta, Alicia
Hagedorn, Catherine
Aguilera‐Garcia, Domingo
Haberecker, Martina
Arnold, Fabian
Herzog, Marius
Bankel, Lorenz
Guggenberger, Roman
Steiner, Sabrina
Chen, Yanjiang
Kahraman, Abdullah
Zoche, Martin
Rubin, Mark A.
Moch, Holger
Britschgi, Christian
Pauli, Chantal

DOI: 10.15252/emmm.202216863

URN: urn:nbn:de:101:1-2023021414011130417526

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Planas-Paz, Lara
Pliego‐Mendieta, Alicia
Hagedorn, Catherine
Aguilera‐Garcia, Domingo
Haberecker, Martina
Arnold, Fabian
Herzog, Marius
Bankel, Lorenz
Guggenberger, Roman
Steiner, Sabrina
Chen, Yanjiang
Kahraman, Abdullah
Zoche, Martin
Rubin, Mark A.
Moch, Holger
Britschgi, Christian
Pauli, Chantal

Other Objects (12)

Leveraging homologous recombination repair deficiency in sarcoma

Homologous recombination deficiency in breast cancer

Targeting homologous recombination deficiency in uterine leiomyosarcoma

Homologous recombination deficiency in epithelial ovarian cancer

Pan-cancer landscape of homologous recombination deficiency

Multi-scale characterisation of homologous recombination deficiency in breast cancer

Tumor homologous recombination deficiency assays: another step closer to clinical application?

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer

Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition

Structural basis of homologous recombination

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer

Leveraging homologous recombination repair deficiency in sarcoma

Homologous recombination deficiency in breast cancer

Targeting homologous recombination deficiency in uterine leiomyosarcoma

Homologous recombination deficiency in epithelial ovarian cancer

Pan-cancer landscape of homologous recombination deficiency

Multi-scale characterisation of homologous recombination deficiency in breast cancer

Tumor homologous recombination deficiency assays: another step closer to clinical application?

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer

Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition

Structural basis of homologous recombination

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer

Leveraging homologous recombination repair deficiency in sarcoma

Homologous recombination deficiency in breast cancer

Targeting homologous recombination deficiency in uterine leiomyosarcoma

Homologous recombination deficiency in epithelial ovarian cancer

Pan-cancer landscape of homologous recombination deficiency

Multi-scale characterisation of homologous recombination deficiency in breast cancer

Tumor homologous recombination deficiency assays: another step closer to clinical application?

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer

Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition

Structural basis of homologous recombination

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Leveraging homologous recombination repair deficiency in sarcoma

Homologous recombination deficiency in breast cancer

Targeting homologous recombination deficiency in uterine leiomyosarcoma

Homologous recombination deficiency in epithelial ovarian cancer

Pan-cancer landscape of homologous recombination deficiency

Multi-scale characterisation of homologous recombination deficiency in breast cancer

Tumor homologous recombination deficiency assays: another step closer to clinical application?

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer

Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition

Structural basis of homologous recombination

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer

Leveraging homologous recombination repair deficiency in sarcoma

Homologous recombination deficiency in breast cancer

Targeting homologous recombination deficiency in uterine leiomyosarcoma

Homologous recombination deficiency in epithelial ovarian cancer

Pan-cancer landscape of homologous recombination deficiency

Multi-scale characterisation of homologous recombination deficiency in breast cancer

Tumor homologous recombination deficiency assays: another step closer to clinical application?

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer

Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition

Structural basis of homologous recombination

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer

Leveraging homologous recombination repair deficiency in sarcoma

Homologous recombination deficiency in breast cancer

Targeting homologous recombination deficiency in uterine leiomyosarcoma

Homologous recombination deficiency in epithelial ovarian cancer

Pan-cancer landscape of homologous recombination deficiency

Multi-scale characterisation of homologous recombination deficiency in breast cancer

Tumor homologous recombination deficiency assays: another step closer to clinical application?

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer

Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition

Structural basis of homologous recombination

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer

Related objects

Reset password